Literature DB >> 18296907

Intra-operative testing for parathyroid hormone: the Central Laboratory option.

L De Pasquale1, D Gobatti, M L Ravini, A Barassi, W Porreca, G V Melzi d'Eril, A Bastagli.   

Abstract

BACKGROUND: Intra-operative PTH testing in the operating theatre has proven to be an accurate way to verify the removal of all pathological parathyroid tissue in primary hyperparathyroidism. Its limitation is the high cost. An alternative, more cost-effective procedure is proposed: intra-operative PTH dosage at the Central Laboratory. PATIENTS AND METHODS: Fifty-four patients underwent parathyroidectomy with intraoperative dosage of PTH at the Central Laboratory. Three blood samples were taken from each patient: just after the induction of anesthesia, 5 and 10 min after parathyroidectomy. The samples were sent to the Central Laboratory and analysed simultaneously. The results were phoned back to the theatre. The procedure was considered effective when PTH drop was >/=50% from basal value, 10 min after parathyroidectomy.
RESULTS: 98.1% of patients proved recovered (average follow- up 31.1 months). The procedure had 3 false negatives, 1 false positive, with sensitivity, specificity, accuracy, positive predictive value and negative predictive value of 94.0%, 75.0%, 92.6%, 97.9%, and 50.0%, respectively. DISCUSSION AND
CONCLUSION: The main disadvantage of the presented procedure is the long waiting time. Nevertheless this time is the same as that required for results from intra-operative histological examination, the only alternative to determine surgery effectiveness in centres where portable instrumentation for intra-operative PTH dosage in the operating theatre is not available. The advantage of intra-operative PTH at the Central Laboratory is the very low cost. If results in terms of sensitivity, specificity, accuracy, and cost are taken into consideration, intra-operative dosage of PTH at the Central Laboratory may be deemed a viable alternative to the operating theatre.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18296907     DOI: 10.1007/bf03345568

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  21 in total

1.  New point-of-care intraoperative parathyroid hormone assay for intraoperative guidance in parathyroidectomy.

Authors:  Denise M Carneiro; George L Irvin
Journal:  World J Surg       Date:  2002-05-21       Impact factor: 3.352

Review 2.  Intraoperative testing for parathyroid hormone: a comprehensive review of the use of the assay and the relevant literature.

Authors:  Alexis Byrne Carter; Peter J Howanitz
Journal:  Arch Pathol Lab Med       Date:  2003-11       Impact factor: 5.534

3.  Intraoperative parathyroid hormone testing: survey of testing program characteristics.

Authors:  Glen L Hortin; Alexis B Carter
Journal:  Arch Pathol Lab Med       Date:  2002-09       Impact factor: 5.534

4.  Kinetic analysis of the rapid intraoperative parathyroid hormone assay in patients during operation for hyperparathyroidism.

Authors:  S K Libutti; H R Alexander; D L Bartlett; M L Sampson; M E Ruddel; M Skarulis; S J Marx; A M Spiegel; W Simmonds; A T Remaley
Journal:  Surgery       Date:  1999-12       Impact factor: 3.982

Review 5.  Surgical treatment of primary hyperparathyroidism.

Authors:  O H Clark
Journal:  Adv Endocrinol Metab       Date:  1995

6.  Minimally invasive, video-assisted parathyroid surgery for primary hyperparathyroidism.

Authors:  P Miccoli; A Pinchera; G Cecchini; M Conte; C Bendinelli; E Vignali; A Picone; C Marcocci
Journal:  J Endocrinol Invest       Date:  1997 Jul-Aug       Impact factor: 4.256

7.  Intraoperative parathyroid hormone measurement in patients with secondary hyperparathyroidism.

Authors:  Fong-Fu Chou; Chiang-Hsuen Lee; Jin-Bor Chen; Kuo-Tai Hsu; Shyr-Ming Sheen-Chen
Journal:  Arch Surg       Date:  2002-03

Review 8.  A systematic review of the diagnosis and treatment of primary hyperparathyroidism from 1995 to 2003.

Authors:  James M Ruda; Christopher S Hollenbeak; Brendan C Stack
Journal:  Otolaryngol Head Neck Surg       Date:  2005-03       Impact factor: 3.497

Review 9.  Rapid intraoperative immunoassay of parathyroid hormone and other hormones: a new paradigm for point-of-care testing.

Authors:  Lori J Sokoll; Frank H Wians; Alan T Remaley
Journal:  Clin Chem       Date:  2004-04-29       Impact factor: 8.327

10.  Primary hyperparathyroidism. Incidence, morbidity, and potential economic impact in a community.

Authors:  H Heath; S F Hodgson; M A Kennedy
Journal:  N Engl J Med       Date:  1980-01-24       Impact factor: 91.245

View more
  5 in total

1.  Is minimally invasive parathyroidectomy without QPTH monitoring justified?

Authors:  Philipp Riss; Christian Scheuba; Reza Asari; Christian Bieglmayer; Bruno Niederle
Journal:  Langenbecks Arch Surg       Date:  2009-05-14       Impact factor: 3.445

2.  Impact of modern techniques on short-term outcome after surgery for primary hyperparathyroidism: a multicenter study comprising 2,708 patients.

Authors:  Anders O J Bergenfelz; Svante K G Jansson; Göran K Wallin; Hans G Mårtensson; Lars Rasmussen; Håkan L O Eriksson; Eva I M Reihnér
Journal:  Langenbecks Arch Surg       Date:  2009-07-18       Impact factor: 3.445

3.  Contribution of intraoperative parathyroid hormone monitoring to the surgical success in minimal invasive parathyroidectomy.

Authors:  Ismail Ethem Akgün; Mehmet Taner Ünlü; Nurcihan Aygun; Mehmet Kostek; Mehmet Uludag
Journal:  Front Surg       Date:  2022-09-21

4.  Markers of Bone Metabolism in Patients With Chronic Pancreatitis and Pancreatic Ductal Adenocarcinoma.

Authors:  Raffaele Pezzilli; Gian Vico Melzi d'Eril; Alessandra Barassi
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

5.  Evaluation of switch from satellite laboratory to central laboratory for testing of intraoperative parathyroid hormone.

Authors:  Denise Jacob; Geeta Lal; Dena R Voss; Tami Bebber; Scott R Davis; Jeff Kulhavy; Sonia L Sugg; Anna E Merrill; Matthew D Krasowski
Journal:  Pract Lab Med       Date:  2020-08-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.